product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Influenza A
catalog :
0300-0234
quantity :
0.2 mg
price :
394 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
1331
application :
ELISA, immunocytochemistry
more info or order :
image
image 1 :
Bio-Rad 0300-0234 image 1
Published customer image: . Mouse anti Influenza A nucleoprotein antibody, clone 1331 ( 0300-0234 ) used to visualize internalized virus by immunofluorescence on infected MDCK cells. Image caption: . Effect of iota-carrageenan on H1N1 virus adsorption and internalization. (A) Adsorption. H1N1 virus was added to MDCK cells in the presence of different concentrations of iota-carrageenan or control polymer carboxymethylcellulose (CMC). After viral adsorption for 1 h at 4 C, cells were washed and the number of cell-bound infectious viral particles determined by plaque assay; red bar 400 ug/ml, orange bar 4 ug/ml iota-carrageenan, black bar 400 ug/ml, grey bar 4 ug/ml CMC. (B) Adsorption/Internalization. H1N1 virus was added to MDCK cells and adsorbed for 1 h at 4 C. Cells were washed and allowed to internalize virus in the presence or absence of different concentrations of iota-carrageenan or CMC for 1 h at 37 C. Subsequently, internalized infectious viral particles were determined by plaque assay. (C) Immunofluorescent visualisation of virus adsorption in the presence of iota-carrageenan or CMC. 1 h post adsorption at 4 C, cells were stained after 1 h at 37 C with a mouse anti-NP antibody. (D) Adsorption/Internalization. H1N1 was added to MDCK cells and adsorbed for 1 h at 4 C. Cells were washed and allowed to internalize virus in the presence of iota-carrageenan or CMC for 1 h at 37 C. Compare the bright green stainings in indicative of productive infection to 5C, where no green fluorescence is detected at high iota-carrageenan concentration. From: Leibbrandt A, Meier C, K nig-Schuster M, Weinm llner R, Kalthoff D, Pflugfelder B, et al. (2010). Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection. PLoS ONE 5(12): e14320.
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
0300-0234
Description :
Mouse anti Influenza A
Specificity :
Influenza A
TargetSpecies :
Viral
Host :
Mouse
Format :
Purified
Isotypes :
IgG2a
Applications :
E,C,IF
ApplicationTypes :
ELISA,Immunohistology - Frozen,Immunofluorescence
Clone :
1331
Quantity :
0.2 mg
Quantity Value :
0.2
Quantity Type :
mg
GO Accessions :
GO:0003723,GO:0030529,GO:0005198,GO:0019012,GO:0042025,GO:0044419
GOTerms :
RNA binding,ribonucleoprotein complex,structural molecule activity,virion,host cell nucleus,interspecies interaction between organisms
Uniprot Accessions :
P18072
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
1.0 mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
281
PriceEUR :
394
PriceUSD :
394 USD
PriceCHF :
429
PriceSEK :
4295
PriceNOK :
4316
PriceDKK :
2938
NotForSaleInCountries :
AU
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.